Vasoconstrictors in erectile physiology

T. M. Mills, K. Chitaley, R. W. Lewis

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

The erectile response of the penis depends on a balance between vasoconstrictor agents which cause cavernosal smooth muscle to contract limiting blood inflow, and vasodilators which relax cavernosal smooth muscle leading to increased blood inflow and erection. This review emphasizes the role of vasoconstrictors in the penis and shows that both endothelin-1 (ET-1) and the α-adrenergic agonist, methoxamine (METHOX) exert strong vasoconstrictor actions in the cavernosal circulation. We recently reported the vasoconstrictor actions of exogenous ET-1 and METHOX to be mediated by the RhoA/Rho-kinase pathway in the cavernosal circulation. While it is widely held that the nitric oxide-cyclic GMP-protein kinase G (NO-cGMP-PKG) pathway mediates vasorelaxation and penile erection, the interaction between this pathway and the vasoconstrictor process remains to be fully elucidated. Our studies also have shown that, during erection, the vasoconstrictor action of METHOX and ET-1 are inhibited and that NO is likely responsible for this inhibition. We hypothesize that the NO-cGMP-PKG pathway controls erection by acting in two distinct ways—by lowering intracellular levels of calcium leading to vasorelaxation and by inhibiting Rho-kinase mediated vasoconstriction.

Original languageEnglish (US)
Pages (from-to)S29-S34
JournalInternational journal of impotence research
Volume13
DOIs
StatePublished - Dec 2001

Fingerprint

Vasoconstrictor Agents
Methoxamine
Endothelin-1
Guanylate Kinases
Cyclic GMP-Dependent Protein Kinases
rho-Associated Kinases
Cyclic GMP
Penis
Vasodilation
Smooth Muscle
Nitric Oxide
Penile Erection
Adrenergic Agonists
Vasoconstriction
Vasodilator Agents
Calcium

Keywords

  • A-adrenergic agonist
  • Endothelin-1
  • Nitric oxide
  • Penile erection
  • Rho-kinase
  • Vasoconstriction

ASJC Scopus subject areas

  • Urology

Cite this

Vasoconstrictors in erectile physiology. / Mills, T. M.; Chitaley, K.; Lewis, R. W.

In: International journal of impotence research, Vol. 13, 12.2001, p. S29-S34.

Research output: Contribution to journalArticle

Mills, T. M. ; Chitaley, K. ; Lewis, R. W. / Vasoconstrictors in erectile physiology. In: International journal of impotence research. 2001 ; Vol. 13. pp. S29-S34.
@article{a95c406d32e24aa59359037d0bc3f743,
title = "Vasoconstrictors in erectile physiology",
abstract = "The erectile response of the penis depends on a balance between vasoconstrictor agents which cause cavernosal smooth muscle to contract limiting blood inflow, and vasodilators which relax cavernosal smooth muscle leading to increased blood inflow and erection. This review emphasizes the role of vasoconstrictors in the penis and shows that both endothelin-1 (ET-1) and the α-adrenergic agonist, methoxamine (METHOX) exert strong vasoconstrictor actions in the cavernosal circulation. We recently reported the vasoconstrictor actions of exogenous ET-1 and METHOX to be mediated by the RhoA/Rho-kinase pathway in the cavernosal circulation. While it is widely held that the nitric oxide-cyclic GMP-protein kinase G (NO-cGMP-PKG) pathway mediates vasorelaxation and penile erection, the interaction between this pathway and the vasoconstrictor process remains to be fully elucidated. Our studies also have shown that, during erection, the vasoconstrictor action of METHOX and ET-1 are inhibited and that NO is likely responsible for this inhibition. We hypothesize that the NO-cGMP-PKG pathway controls erection by acting in two distinct ways—by lowering intracellular levels of calcium leading to vasorelaxation and by inhibiting Rho-kinase mediated vasoconstriction.",
keywords = "A-adrenergic agonist, Endothelin-1, Nitric oxide, Penile erection, Rho-kinase, Vasoconstriction",
author = "Mills, {T. M.} and K. Chitaley and Lewis, {R. W.}",
year = "2001",
month = "12",
doi = "10.1038/sj.ijir.3900774",
language = "English (US)",
volume = "13",
pages = "S29--S34",
journal = "International Journal of Impotence Research",
issn = "0955-9930",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Vasoconstrictors in erectile physiology

AU - Mills, T. M.

AU - Chitaley, K.

AU - Lewis, R. W.

PY - 2001/12

Y1 - 2001/12

N2 - The erectile response of the penis depends on a balance between vasoconstrictor agents which cause cavernosal smooth muscle to contract limiting blood inflow, and vasodilators which relax cavernosal smooth muscle leading to increased blood inflow and erection. This review emphasizes the role of vasoconstrictors in the penis and shows that both endothelin-1 (ET-1) and the α-adrenergic agonist, methoxamine (METHOX) exert strong vasoconstrictor actions in the cavernosal circulation. We recently reported the vasoconstrictor actions of exogenous ET-1 and METHOX to be mediated by the RhoA/Rho-kinase pathway in the cavernosal circulation. While it is widely held that the nitric oxide-cyclic GMP-protein kinase G (NO-cGMP-PKG) pathway mediates vasorelaxation and penile erection, the interaction between this pathway and the vasoconstrictor process remains to be fully elucidated. Our studies also have shown that, during erection, the vasoconstrictor action of METHOX and ET-1 are inhibited and that NO is likely responsible for this inhibition. We hypothesize that the NO-cGMP-PKG pathway controls erection by acting in two distinct ways—by lowering intracellular levels of calcium leading to vasorelaxation and by inhibiting Rho-kinase mediated vasoconstriction.

AB - The erectile response of the penis depends on a balance between vasoconstrictor agents which cause cavernosal smooth muscle to contract limiting blood inflow, and vasodilators which relax cavernosal smooth muscle leading to increased blood inflow and erection. This review emphasizes the role of vasoconstrictors in the penis and shows that both endothelin-1 (ET-1) and the α-adrenergic agonist, methoxamine (METHOX) exert strong vasoconstrictor actions in the cavernosal circulation. We recently reported the vasoconstrictor actions of exogenous ET-1 and METHOX to be mediated by the RhoA/Rho-kinase pathway in the cavernosal circulation. While it is widely held that the nitric oxide-cyclic GMP-protein kinase G (NO-cGMP-PKG) pathway mediates vasorelaxation and penile erection, the interaction between this pathway and the vasoconstrictor process remains to be fully elucidated. Our studies also have shown that, during erection, the vasoconstrictor action of METHOX and ET-1 are inhibited and that NO is likely responsible for this inhibition. We hypothesize that the NO-cGMP-PKG pathway controls erection by acting in two distinct ways—by lowering intracellular levels of calcium leading to vasorelaxation and by inhibiting Rho-kinase mediated vasoconstriction.

KW - A-adrenergic agonist

KW - Endothelin-1

KW - Nitric oxide

KW - Penile erection

KW - Rho-kinase

KW - Vasoconstriction

UR - http://www.scopus.com/inward/record.url?scp=0035670429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035670429&partnerID=8YFLogxK

U2 - 10.1038/sj.ijir.3900774

DO - 10.1038/sj.ijir.3900774

M3 - Article

C2 - 11781744

AN - SCOPUS:0035670429

VL - 13

SP - S29-S34

JO - International Journal of Impotence Research

JF - International Journal of Impotence Research

SN - 0955-9930

ER -